ERBB2 and cervical adenocarcinoma: However, some important relevant aspects remain unresolved in cervical adenocarcinomas, such as the clinical significance, the precise prevalence and the histotype distribution of HER2 overexpression, and the concordance between HER2 immunohistochemical results and gene amplification.